Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) Other Non Operating Income (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Other Non Operating Income for 17 consecutive years, with -$13000.0 as the latest value for Q1 2026.

  • Quarterly Other Non Operating Income fell 161.9% to -$13000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$70000.0 through Mar 2026, up 86.59% year-over-year, with the annual reading at -$36000.0 for FY2025, 87.28% up from the prior year.
  • Other Non Operating Income for Q1 2026 was -$13000.0 at Achieve Life Sciences, down from $7000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $59000.0 in Q4 2022, with the low at -$283000.0 in Q3 2024.
  • Average Other Non Operating Income over 5 years is -$33882.4, with a median of -$5000.0 recorded in 2025.
  • The widest YoY moves for Other Non Operating Income: up 251.28% in 2022, down 2900.0% in 2022.
  • Achieve Life Sciences' Other Non Operating Income stood at $59000.0 in 2022, then tumbled by 71.19% to $17000.0 in 2023, then tumbled by 1617.65% to -$258000.0 in 2024, then surged by 102.71% to $7000.0 in 2025, then crashed by 285.71% to -$13000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Other Non Operating Income are -$13000.0 (Q1 2026), $7000.0 (Q4 2025), and -$5000.0 (Q3 2025).